Back to Search Start Over

Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.

Authors :
Cattelan G
Sophie Frommelt L
Volani C
Colliva A
Ciucci G
Paldino A
Dal Ferro M
Di Segni M
Silipigni R
Pramstaller PP
De Bortoli M
Zacchigna S
Rossini A
Source :
Stem cell research [Stem Cell Res] 2023 Sep; Vol. 71, pp. 103172. Date of Electronic Publication: 2023 Jul 28.
Publication Year :
2023

Abstract

Dilated cardiomyopathy (DCM) is a common heart disorder caused by genetic and non-genetic etiologies, characterized by left ventricular dilatation and contractile dysfunction. Here, we created a human induced pluripotent stem cell line from peripheral blood mononuclear cells using non-integrating vectors from a patient carrying a heterozygous LMNA variant (c.481G > A, p.Glu161Lys, NM_170707.4). The obtained EURACi015-A line, showed the typical morphology of pluripotent cells, normal karyotype and exhibited pluripotency markers and a trilineage differentiation potential. This cell line can be successfully differentiated into cardiomyocytes and endothelial cells. This line represents a human in vitro model to study the genetic basis of DCM.<br />Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alessandra Rossini and Serena Zacchigna reports financial support was provided by European Regional Development Fund.<br /> (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1876-7753
Volume :
71
Database :
MEDLINE
Journal :
Stem cell research
Publication Type :
Academic Journal
Accession number :
37535990
Full Text :
https://doi.org/10.1016/j.scr.2023.103172